Protein Profiling Identifies mTOR Pathway Modulation and Cytostatic Effects of Pim Kinase Inhibitor, AZD1208, in Acute Myeloid Leukemia

類似資料

• The novel combination of dual mTOR inhibitor AZD2014 and pan-PIM inhibitor AZD1208 inhibits growth in acute myeloid leukemia via HSF pathway suppression
  著者:: Harada, Masako, 等
  出版事項: (2015)
• PIM kinase inhibitor, AZD1208, inhibits protein translation and induces autophagy in primary chronic lymphocytic leukemia cells
  著者:: Cervantes-Gomez, Fabiola, 等
  出版事項: (2019)
• Mechanisms of cytotoxicity to Pim kinase inhibitor, SGI-1776, in acute myeloid leukemia
  著者:: Chen, Lisa S., 等
  出版事項: (2011)
• AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia
  著者:: Keeton, Erika K., 等
  出版事項: (2014)
• PIM Kinase Inhibitor AZD1208 for Treatment of MYC-Driven Prostate Cancer
  著者:: Kirschner, Austin N., 等
  出版事項: (2014)